Next |
home / stock / acrs / acrs message board
Subject | By | Source | When |
---|---|---|---|
I was short premarket 20.30 then quickly covered | alchemytrader | investorshub | 01/20/2021 10:19:02 PM |
ACRS offering more than 5m shares at $17.50/per share | SteevoTrader | investorshub | 01/20/2021 2:01:58 PM |
The way she kept grinding back to 19s | alchemytrader | investorshub | 01/20/2021 4:50:21 AM |
Are we seeing a dump tomorrow? | SteevoTrader | investorshub | 01/20/2021 1:57:36 AM |
Oh really? hit 19.95 today... | alchemytrader | investorshub | 01/20/2021 12:55:29 AM |
* * $ACRS Video Chart 01-19-2021 * * | ClayTrader | investorshub | 01/19/2021 10:40:22 PM |
One month later. Take a look now. E-trade | Marketwise | investorshub | 01/19/2021 5:37:35 PM |
Nice! | Docstemcell2020 | investorshub | 01/19/2021 2:28:03 PM |
Im so happy Etrade wouldnt let me buy | Serge521 | investorshub | 12/22/2020 3:49:15 PM |
So $ACRS trials will take 2 years but | interloper | investorshub | 08/20/2020 3:55:50 PM |
$ACRS Trials gets an update from the FDA. | DanSanTrades | investorshub | 08/17/2020 2:06:19 PM |
* * $ACRS Video Chart 07-20-2020 * * | ClayTrader | investorshub | 07/20/2020 9:33:46 PM |
* * $ACRS Video Chart 06-17-2020 * * | ClayTrader | investorshub | 06/17/2020 8:16:47 PM |
* * $ACRS Video Chart 01-10-2020 * * | ClayTrader | investorshub | 01/10/2020 8:58:13 PM |
good Volume | beambe | investorshub | 01/10/2020 3:36:29 PM |
Just a shout out here, anyone with fundamental | XenaLives | investorshub | 12/26/2019 1:05:35 PM |
3 Penny Stocks To Watch As Biotech Hits | jonny_red | investorshub | 10/31/2019 12:39:32 PM |
* * $ACRS Video Chart 10-29-2019 * * | ClayTrader | investorshub | 10/29/2019 8:43:51 PM |
$ACRS Overbought Aclaris Therapeutics ($ACRS) May Report Negative Earnings | BottomBounce | investorshub | 10/29/2019 7:06:15 PM |
3 Best Penny Stocks To Trade Before Next | jonny_red | investorshub | 10/28/2019 2:34:19 PM |
News, Short Squeeze, Breakout and More Instantly...
Aclaris Therapeutics Inc. Company Name:
ACRS Stock Symbol:
NASDAQ Market:
Aclaris Therapeutics Inc. Website:
- Progressing ATI-2138 into Atopic Dermatitis - - Management to Host Conference Call at 5:00 PM ET Today - WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidat...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...
BioCryst Pharmaceuticals (NASDAQ: BCRX) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.23. T...